A Long-term Trial of OPC-34712 in Patients With Schizophrenia

Trial Evaluating OPC-34712 in Subjects With Normal Renal Function and Renally Impaired Subjects

NCT01289080 ·Status: COMPLETED ·Phase: PHASE1

Positron Emission Tomagraphy (PET) Study Following a Single Oral Dose of OPC-34712

NCT00805454 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for Treatment of Acute Schizophrenia

NCT00905307 ·Status: COMPLETED ·Phase: PHASE2

Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Male and Female Subjects With Schizophrenia

NCT01994473 ·Status: COMPLETED ·Phase: PHASE1

A Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Male and Female Subjects With Schizophrenia

NCT01940159 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic Adults With Schizophrenia

NCT02969382 ·Status: COMPLETED ·Phase: PHASE2

A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia

NCT06894212 ·Status: RECRUITING ·Phase: PHASE3

A Clinical Study to Evaluate the Long-term Safety and Tolerability of an Investigational Drug in People With Schizophrenia

NCT04109950 ·Status: TERMINATED ·Phase: PHASE3

Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia

NCT01396421 ·Status: COMPLETED ·Phase: PHASE3

A Clinical Trial to Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia

NCT04072354 ·Status: COMPLETED ·Phase: PHASE3

Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral Brexpiprazole (OPC- 34712) in Adolescents With Schizophrenia

NCT02411695 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Study That Will Evaluate How Well SEP-363856 Works and How Safe it is in People With Schizophrenia That Switch to SEP-363856 From Their Current Antipsychotic Medication

NCT05628103 ·Status: COMPLETED ·Phase: PHASE3

A Clinical Study to Investigate the Effect of an Investigational Drug as an Added Medication to an Antipsychotic, in Adults With Schizophrenia, as Measured Positron Emission Tomography (PET) Imaging

NCT04038957 ·Status: COMPLETED ·Phase: PHASE1

A First In Human Study Of PF-00184562 In Healthy Volunteers

NCT00150215 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1 Safety Study in Adults With Schizophrenia

NCT02804568 ·Status: COMPLETED ·Phase: PHASE1

Long-Term Efficacy and Safety of Asenapine Using Olanzapine as a Positive Control (41512)(COMPLETED)(P05784)

NCT00156091 ·Status: COMPLETED ·Phase: PHASE3

Double Blind, Placebo-Controlled, Randomised Investigation of Ondansetron in Schizophrenia

NCT01121042 ·Status: COMPLETED ·Phase: PHASE3

Open-label Trial Characterizing the PK of 3 SC Olanzapine Extended-release Formulations in Participants With Schizophrenia/Schizoaffective Disorder

NCT06319170 ·Status: COMPLETED ·Phase: PHASE1

A Study to Determine the Efficacy and Safety of 2 Doses of Org 34517 as Adjunctive Therapy in Subjects With Psychotic Major Depression (28130)(P05845)

NCT00212797 ·Status: COMPLETED ·Phase: PHASE2

A Clinical Study to Learn if SEP-363856 Has Physical Dependence in Adults With Schizophrenia

NCT05848700 ·Status: COMPLETED ·Phase: PHASE1

A Study of Olanzapine in Patients With Schizophrenia

NCT00970281 ·Status: COMPLETED ·Phase: PHASE3

Safety, Tolerability, and Pharmacokinetics of OMS643762 in Psychiatrically Stable Schizophrenia Subjects

NCT01952132 ·Status: COMPLETED ·Phase: PHASE2

A Clinical Study That Will Assess How Food Moves Through the Stomach and Effects Blood Glucose Levels in Subjects With Schizophrenia Taking SEP-363856 or and Prior Antipsychotic (PA) Standard

NCT05402111 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of Asenapine With Placebo and Olanzapine (41021)(P05933)

NCT00156117 ·Status: COMPLETED ·Phase: PHASE3

A Study of Olanzapine in Patients With Acute Agitation

NCT05803642 ·Status: UNKNOWN ·Phase: PHASE3